[go: up one dir, main page]

WO2011074015A3 - Composition of pharmaceutical product to treat sexual dysfunction - Google Patents

Composition of pharmaceutical product to treat sexual dysfunction Download PDF

Info

Publication number
WO2011074015A3
WO2011074015A3 PCT/IN2010/000824 IN2010000824W WO2011074015A3 WO 2011074015 A3 WO2011074015 A3 WO 2011074015A3 IN 2010000824 W IN2010000824 W IN 2010000824W WO 2011074015 A3 WO2011074015 A3 WO 2011074015A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
pharmaceutical product
sexual dysfunction
treat sexual
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2010/000824
Other languages
French (fr)
Other versions
WO2011074015A2 (en
Inventor
Dinesh Shantilal Patel
Sachin Dinesh Patel
Shashikant Prabhudas Kurani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Themis Medicare Ltd
Original Assignee
Themis Medicare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Themis Medicare Ltd filed Critical Themis Medicare Ltd
Publication of WO2011074015A2 publication Critical patent/WO2011074015A2/en
Publication of WO2011074015A3 publication Critical patent/WO2011074015A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Disclosed herein is topical pharmaceutical composition comprising Lidocaine or it pharmaceutically acceptable salts in combination with one or more other local anesthetic agent(s) along with propellants, solvents and other pharmaceutically acceptable excipient useful for the treatment of premature ejaculation and like conditions optionally with additional therapeutic active ingredient(s).
PCT/IN2010/000824 2009-12-17 2010-12-16 Novel composition of pharmaceutical product to treat sexual dysfunction Ceased WO2011074015A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2920/MUM/2009 2009-12-17
IN2920MU2009 2009-12-17

Publications (2)

Publication Number Publication Date
WO2011074015A2 WO2011074015A2 (en) 2011-06-23
WO2011074015A3 true WO2011074015A3 (en) 2012-04-26

Family

ID=44021871

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2010/000824 Ceased WO2011074015A2 (en) 2009-12-17 2010-12-16 Novel composition of pharmaceutical product to treat sexual dysfunction

Country Status (1)

Country Link
WO (1) WO2011074015A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8637577B2 (en) 2009-01-22 2014-01-28 Absorption Pharmaceuticals, LLC Desensitizing drug product
WO2015116427A1 (en) * 2014-01-28 2015-08-06 Harry Fisch Individually-packed wipes for enhancing sexual intercourse
JP7488644B2 (en) * 2018-11-30 2024-05-22 興和株式会社 Pharmaceuticals
US11576920B2 (en) 2019-03-18 2023-02-14 The Menopause Method, Inc. Composition and method to aid in hormone replacement therapy
CN111658675A (en) * 2020-06-16 2020-09-15 欧阳志华 Composition for treating male sexual function and preparation method thereof
CN115191639A (en) * 2021-04-12 2022-10-18 深圳市合元科技有限公司 Aerosol-forming substrate and aerosol-generating system
CN116019769A (en) * 2021-10-26 2023-04-28 深圳市合元科技有限公司 Liquid preparation and method for its preparation, aerosol generating system, cartridge for aerosol generating system, and aerosol generating device
CN114533658A (en) * 2022-03-04 2022-05-27 郭建芳 Composition for treating premature ejaculation by SS-PE and preparation method thereof
CN114767624A (en) * 2022-05-10 2022-07-22 南京唯创远医药科技有限公司 Pharmaceutical composition containing 4-butoxy-beta-piperidyl propiophenone compound and preparation method and application thereof
CN116570718B (en) * 2023-04-26 2025-09-30 四川大学华西医院 A pharmaceutical composition comprising a local anesthetic and fospropofol disodium, its preparation method and use, and a combined drug
WO2025032365A1 (en) * 2023-08-04 2025-02-13 Satnam Singh A composition for desensitizing a body part

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453445A (en) * 1994-05-02 1995-09-26 Henry; Richard A. Lidocaine-phenylephrine aerosol preparation
WO2004084878A1 (en) * 2003-03-21 2004-10-07 Nexmed (Holdings), Inc. Compositions and methods for treatment of premature ejaculation
US20090093547A1 (en) * 2007-10-09 2009-04-09 Sciele Pharma, Inc. Compositions and Methods for Treating Premature Ejaculation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7713618L (en) 1977-12-01 1979-06-02 Astra Laekemedel Ab LOCAL ANESTHETIC MIXTURE
US5446070A (en) 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
SE8802040D0 (en) 1988-06-01 1988-06-01 Astra Ab NEW USE
JP3115625B2 (en) 1991-03-30 2000-12-11 帝國製薬株式会社 Topical patch containing lidocaine
SE9200762D0 (en) 1992-03-12 1992-03-12 Astra Ab NEW TOPICAL USE
US5593661A (en) 1993-03-29 1997-01-14 Henry; Richard A. Lidocaine aerosol anaesthetic
US5858331A (en) 1994-05-02 1999-01-12 Henry; Richard A. Prilocaine and hydrofluorocarbon aerosol preparations
SE9601421D0 (en) 1996-04-12 1996-04-12 Astra Ab New composition
US5698227A (en) 1996-07-23 1997-12-16 Rivlin; Daniel Compositions comprising lidocaine and emu oil and methods of use thereof
US6299902B1 (en) 1999-05-19 2001-10-09 The University Of Georgia Research Foundation, Inc. Enhanced transdermal anesthesia of local anesthetic agents
US20020006435A1 (en) 2000-01-27 2002-01-17 Samuels Paul J. Transdermal anesthetic and vasodilator composition and methods for topical administration
ES2223277B1 (en) 2003-06-19 2006-03-01 Fernando Bouffard Fita ANESTHETIC COMPOSITION FOR TOPICAL ADMINISTRATION.
CN101404992A (en) 2006-02-17 2009-04-08 N·D·扎斯勒 New use of local anesthetic for regulating neurogenic tremor
CA2696523A1 (en) 2007-08-22 2009-02-26 Jeffrey Carpenter Novel application of topical anesthetics for modulation of neurogenic tremor

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453445A (en) * 1994-05-02 1995-09-26 Henry; Richard A. Lidocaine-phenylephrine aerosol preparation
WO2004084878A1 (en) * 2003-03-21 2004-10-07 Nexmed (Holdings), Inc. Compositions and methods for treatment of premature ejaculation
US20090093547A1 (en) * 2007-10-09 2009-04-09 Sciele Pharma, Inc. Compositions and Methods for Treating Premature Ejaculation

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HYUNG KI CHOI ET AL: "Clinical study of SS-cream in patients with lifelong premature ejaculation", UROLOGY, vol. 55, no. 2, 1 February 2000 (2000-02-01), pages 257 - 261, XP055014751, ISSN: 0090-4295, DOI: 10.1016/S0090-4295(99)00415-X *
R HENRY ET AL: "Topical lidocaine-prilocaine spray for the treatment of premature ejaculation: a proof of concept study", INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, vol. 15, no. 4, 1 August 2003 (2003-08-01), pages 277 - 281, XP055014787, ISSN: 0955-9930, DOI: 10.1038/sj.ijir.3901011 *

Also Published As

Publication number Publication date
WO2011074015A2 (en) 2011-06-23

Similar Documents

Publication Publication Date Title
WO2011074015A3 (en) Composition of pharmaceutical product to treat sexual dysfunction
WO2009109613A3 (en) 1-BENZYL-3-HYDROXYMETHYLINDAZOIιE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF DISEASES BASED ON THE EXPRESSION OF MCP-1, CX3CR1
WO2008116195A3 (en) Compositions comprising an sglt2 ingibitor for treating obesity
WO2009109616A8 (en) 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40
WO2012005500A3 (en) Time-delayed sustained release pharmaceutical composition comprising dapoxetine for oral administration
MY208749A (en) Biligand drug conjugates and uses thereof
WO2011107755A3 (en) Immediate/delayed drug delivery
WO2012007159A3 (en) Novel gastro-retentive dosage forms
WO2009109654A8 (en) 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, and cx3cr1
NZ703808A (en) Topical transdermal dexmedetomidine compositions and methods of use thereof
WO2010116385A3 (en) Pharmaceutical compositions for alleviating unpleasant taste
AU2018256619A1 (en) Compounds for the treatment of obesity and methods of use thereof
WO2008116890A3 (en) Pharmaceutical compositions comprising flibanserin and a further agent in the treatment of sexual disorders
WO2011049327A3 (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
MX2009011900A (en) Diabetic wound healing.
WO2008070010A3 (en) Hydroxylamine derivatives for the treatment of stroke
GB2456475A (en) Composition for the treatment of skin conditions
WO2005107810A3 (en) Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction
WO2008058210A3 (en) Local administration of gallium compositions to treat pain
WO2006071601A3 (en) Therapeutic compositions for intranasal administration of ketorolac
RU2011148355A (en) APPLICATION OF ALLOPURINOL FOR PALM AND PERSONAL SYNDROME
WO2008008882A3 (en) Glucocorticoid receptor modulator and methods of use
WO2014119985A3 (en) Pharmaceutical composition comprising a selective phosphodiesterase enzyme inhibitor in oral gel form
WO2008051527A3 (en) Sustained release of agents for localized pain management
BRPI0918593A2 (en) pharmaceutical composition for use in the treatment of sexually transmitted infections

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10822881

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10822881

Country of ref document: EP

Kind code of ref document: A2